|
1
|
Mattei TA, Rehman AA, Issawi A and Fassett
DR: Surgical challenges in the management of cervical kyphotic
deformity in patients with severe osteoporosis: An illustrative
case of a patient with Hajdu-Cheney syndrome. Eur Spine J.
24:2746–2753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohtori S, Akazawa T, Murata Y, Kinoshita
T, Yamashita M, Nakagawa K, Inoue G, Nakamura J, Orita S, Ochiai N,
et al: Risedronate decreases bone resorption and improves low back
pain in postmenopausal osteoporosis patients without vertebral
fractures. J Clin Neurosci. 17:209–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Otrock ZK, Azar ST, Shamseddeen WA, Habr
D, Inati A, Koussa S, Mahfouz RA and Taher AT: Intravenous
zoledronic acid treatment in thalassemia-induced osteoporosis:
Results of a phase II clinical trial. Ann Hematol. 85:605–609.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bastian L, Schils F, Tillman JB and
Fueredi G: SCORE Investigators: A randomized trial comparing 2
techniques of balloon kyphoplasty and curette use for obtaining
vertebral body height restoration and angular-deformity correction
in vertebral compression fractures due to osteoporosis. AJNR Am J
Neuroradiol. 34:666–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang Y, Zeng Y, Huang X, Qin Y, Luo W,
Xiang S, Sooranna SR and Pinhu L: Nur77 attenuates endothelin-1
expression via downregulation of NF-κB and p38 MAPK in A549 cells
and in an ARDS rat model. Am J Physiol Lung Cell Mol Physiol.
311:L1023–L1035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dvir-Ginzberg M and Steinmeyer J: Towards
elucidating the role of SirT1 in osteoarthritis. Front Biosci
(Landmark Ed). 18:343–355. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai B, Vanhoutte PM and Wang Y:
Loss-of-SIRT1 function during vascular ageing: Hyperphosphorylation
mediated by cyclin-dependent kinase 5. Trends Cardiovasc Med.
24:81–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jung-Hynes B and Ahmad N: SIRT1 controls
circadian clock circuitry and promotes cell survival: A connection
with age-related neoplasms. FASEB J. 23:2803–2809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Javkhedkar AA and Banday AA: Antioxidant
resveratrol restores renal sodium transport regulation in SHR.
Physiol Rep. 3:pii: e12618. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McGill MR, Du K, Weemhoff JL and Jaeschke
H: Critical review of resveratrol in xenobiotic-induced
hepatotoxicity. Food Chem Toxicol. 86:309–318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shankar S, Singh G and Srivastava RK:
Chemoprevention by resveratrol: Molecular mechanisms and
therapeutic potential. Front Biosci. 12:4839–4854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao L, Wang Y, Wang Z, Xu Z, Zhang Q and
Yin M: Effects of dietary resveratrol on excess-iron-induced bone
loss via antioxidative character. J Nutr Biochem. 26:1174–1182.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szkudelski T and Szkudelska K: Resveratrol
and diabetes: From animal to human studies. Biochim Biophys Acta.
1852:1145–1154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JH, Kim JS, Park SY and Lee YJ:
Resveratrol induces human keratinocyte damage via the activation of
class III histone deacetylase, Sirt1. Oncol Rep. 35:524–529. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumar S, Eroglu E, Stokes JA III,
Scissum-Gunn K, Saldanha SN, Singh UP, Manne U, Ponnazhagan S and
Mishra MK: Resveratrol induces mitochondria-mediated,
caspase-independent apoptosis in murine prostate cancer cells.
Oncotarget. 8:20895–20908. 2017.PubMed/NCBI
|
|
16
|
Lopez MS, Dempsey RJ and Vemuganti R:
Resveratrol neuroprotection in stroke and traumatic CNS injury.
Neurochem Int. 89:75–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Ligt M, Timmers S and Schrauwen P:
Resveratrol and obesity: Can resveratrol relieve metabolic
disturbances? Biochim Biophys Acta. 1852:1137–1144. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ozcicek A, Cetin N, Cimen Keskin F,
Tumkaya L, Malkoc I, Gulaboglu M, Yarali O and Suleyman B: The
impact of resveratrol on oxidative stress induced by methotrexate
in rat ileum tissue: Evaluation of biochemical and
histopathological features and analysis of gene expression. Med
Princ Pract. 25:181–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mathavan N, Bosemark P, Isaksson H and
Tägil M: Investigating the synergistic efficacy of BMP-7 and
zoledronate on bone allografts using an open rat osteotomy model.
Bone. 56:440–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khajuria DK, Razdan R, Mahapatra DR and
Bhat MR: Osteoprotective effect of propranolol in ovariectomized
rats: A comparison with zoledronic acid and alfacalcidol. J Orthop
Sci. 18:832–842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gamsjaeger S, Buchinger B, Zwettler E,
Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K and
Paschalis EP: Bone material properties in actively bone-forming
trabeculae in postmenopausal women with osteoporosis after three
years of treatment with once-yearly Zoledronic acid. J Bone Miner
Res. 26:12–18. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Haines CJ, Chung TK, Leung PC, Hsu SY and
Leung DH: Calcium supplementation and bone mineral density in
postmenopausal women using estrogen replacement therapy. Bone.
16:529–531. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang T, Pang L, Huang H and Wang WY:
Observation on influence of bone metabolism biochemical indices of
senile osteoporosis treated with distant acupuncture and nearby
tuina. Zhongguo Zhen Jiu. 32:13–16. 2012.(In Chinese). PubMed/NCBI
|
|
24
|
Pedraza CE, Marelli B, Chicatun F, McKee
MD and Nazhat SN: An in vitro assessment of a cell-containing
collagenous extracellular matrix-like scaffold for bone tissue
engineering. Tissue Eng Part A. 16:781–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reid JW, Pietak A, Sayer M, Dunfield D and
Smith TJ: Phase formation and evolution in the silicon substituted
tricalcium phosphate/apatite system. Biomaterials. 26:2887–2897.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levaot N, Simoncic PD, Dimitriou ID,
Scotter A, La Rose J, Ng AH, Willett TL, Wang CJ, Janmohamed S,
Grynpas M, et al: 3BP2-deficient mice are osteoporotic with
impaired osteoblast and osteoclast functions. J Clin Invest.
121:3244–3257. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nowwarote N, Osathanon T, Jitjaturunt P,
Manopattanasoontorn S and Pavasant P: Asiaticoside induces type I
collagen synthesis and osteogenic differentiation in human
periodontal ligament cells. Phytother Res. 27:457–462. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He N, Zhu X, He W, Zhao S, Zhao W and Zhu
C: Resveratrol inhibits the hydrogen dioxide-induced apoptosis via
Sirt 1 activation in osteoblast cells. Biosci Biotechnol Biochem.
79:1779–1786. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shakibaei M, Shayan P, Busch F, Aldinger
C, Buhrmann C, Lueders C and Mobasheri A: Resveratrol mediated
modulation of Sirt-1/Runx2 promotes osteogenic differentiation of
mesenchymal stem cells: Potential role of Runx2 deacetylation. PLoS
One. 7:e357122012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saravanan S, Vimalraj S, Vairamani M and
Selvamurugan N: Role of mesoporous wollastonite (Calcium Silicate)
in mesenchymal stem cell proliferation and osteoblast
differentiation: A cellular and molecular study. J Biomed
Nanotechnol. 11:1124–1138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sin TK, Yung BY, Yip SP, Chan LW, Wong CS,
Tam EW and Siu PM: SIRT1-dependent myoprotective effects of
resveratrol on muscle injury induced by compression. Front Physiol.
6:2932015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang F, Lu M, Wang H and Ren T: Aspirin
attenuates angiotensin II-induced inflammation in bone marrow
mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB
activation. Biomed Rep. 1:930–934. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu CM, Chen PC, Li TM, Fong YC and Tang
CH: Si-Wu-tang extract stimulates bone formation through
PI3K/Akt/NF-κB signaling pathways in osteoblasts. BMC Complement
Altern Med. 13:2772013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao Z, Li Y, Yin X, Dong Y, Xing L and
Boyce BF: NF-κB RelB negatively regulates osteoblast
differentiation and bone formation. J Bone Miner Res. 29:866–877.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tsubaki M, Takeda T, Kino T, Itoh T, Imano
M, Tanabe G, Muraoka O, Satou T and Nishida S: Mangiferin
suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β
and RANKL through inhibiting the activation of NF-κB and ERK1/2. Am
J Transl Res. 7:1371–1381. 2015.PubMed/NCBI
|
